Chatting with Rachel Haurwitz, CEO, Caribou Bio

Published on: 

Pharmaceutical Executive

Rachel Haurwitz, CEO, Caribou Bio, discusses Caribou's technology for gene editing with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event.

Rachel Haurwitz, CEO, Caribou Bio, discusses Caribou's technology for gene editing with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event.  

Related Content:

Editorial Videos
Workforce Trends in Pharma & Psychological Safety
DE&I Accountability in Pharma
Attracting Young Talent in Pharma